Extramitral Valvular Cardiac Involvement in Patients With Significant Secondary Mitral Regurgitation

dc.contributor.authorSingh Gurpreet K.
dc.contributor.authorNamazi Farnaz
dc.contributor.authorHirasawa Kensuke
dc.contributor.authorvan der Bijl Pieter
dc.contributor.authorvan Wijngaarden Aniek L.
dc.contributor.authorVo N. Mai
dc.contributor.authorStone Gregg W.
dc.contributor.authorAjmone Marsan Nina
dc.contributor.authorDelgado Victoria
dc.contributor.authorBax Jeroen J.
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.converis.publication-id67833061
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/67833061
dc.date.accessioned2022-10-27T11:57:37Z
dc.date.available2022-10-27T11:57:37Z
dc.description.abstract<p>Patients with secondary mitral regurgitation (SMR) often have extramitral valve cardiac involvement, which can influence the prognosis. SMR can be defined according to groups of extramitral valve cardiac involvement. The prognostic implications of such groups in patients with moderate and severe SMR (significant SMR) are unknown. A total of 325 patients with significant SMR were classified according to the extent of cardiac involvement on echocardiography: left ventricular involvement (group 1), left atrial involvement (group 2), tricuspid valve and pulmonary artery vasculature involvement (group 3), or right ventricular involvement (group 4). The primary end point was all-cause mortality. The prevalence of each cardiac involvement group was 17% in group 1, 12% in group 2, 23% in group 3%, and 48% in group 4. Group 3 and group 4 were independently associated with all-cause mortality (hazard ratio 1.794, 95% confidence interval 1.067 to 3.015, p = 0.027 and hazard ratio 1.857, 95% confidence interval 1.145 to 3.012, p = 0.012, respectively). In conclusion, progressive extramitral valve cardiac involvement (group 3 and group 4) was independently associated with all-cause mortality in patients with significant SMR.<br></p>
dc.format.pagerange143
dc.format.pagerange149
dc.identifier.eissn1879-1913
dc.identifier.jour-issn0002-9149
dc.identifier.olddbid173117
dc.identifier.oldhandle10024/156211
dc.identifier.urihttps://www.utupub.fi/handle/11111/30955
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0002914921009334?via%3Dihub
dc.identifier.urnURN:NBN:fi-fe2021120158346
dc.language.isoen
dc.okm.affiliatedauthorBax, Jeroen
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3126 Surgery, anesthesiology, intensive care, radiologyen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.discipline3126 Kirurgia, anestesiologia, tehohoito, radiologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier Inc.
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1016/j.amjcard.2021.09.022
dc.relation.ispartofjournalAmerican Journal of Cardiology
dc.relation.volume162
dc.source.identifierhttps://www.utupub.fi/handle/10024/156211
dc.titleExtramitral Valvular Cardiac Involvement in Patients With Significant Secondary Mitral Regurgitation
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0002914921009334-main (1).pdf
Size:
559.91 KB
Format:
Adobe Portable Document Format